be_ixf;ym_202001 d_23; ct_50

Select Page

Nick Tate

Nick TateNick Tate Senior Editorial Manager for Bold Profits Daily, Profits Unlimited and Paul Mampilly’s other premium trading publications.

Nick Tate is the senior editorial manager for Bold Profits Daily, Profits Unlimited and Paul Mampilly’s other premium trading publications.

As a best-selling author, seasoned journalist and TV commentator specializing in health care, finance and biotech, Nick is all about big ideas and innovations — always keeping his followers informed on the next big thing.

His work has appeared in The Miami Herald, The Atlanta Journal-Constitution, South Florida Business Journal, Newsmax Magazine, South Florida Sun Sentinel, Boston Herald, and on Newsmax TV and the Al Jazeera network.

His top-selling book, the ObamaCare Survival Guide, was on the Publishers Weekly and The New York Times best-sellers lists for 22 weeks — reaching No. 1 on The Times list for paperback advice books.

Tate also co-authored DaVinci’s Baby Boomer Survival Guide: Live, Prosper, and Thrive in Your Retirement. And he published two other books — the Encyclopedia of Natural Healing and The Sick Building Syndrome — following a year-long journalism fellowship at the Harvard School of Public Health.

Tate’s three-decades-long commitment to keeping the public well-informed is why Banyan Hill Publishing recruited him in 2018 to join Paul Mampilly’s team. You can now read Nick’s weekly analysis in Bold Profits Daily as he guides over 130,000 readers on the best ways to grow their wealth.

Nick Tate's Articles

Top Stocks for America 2.0’s Telehealth Revolution - The next generation of telehealth tools is here — artificial intelligence, better remote sensors and genetics — remaking U.S. health care with a new, personal, “virtual” spin.
3D printing and precision medicine 3D Printing + Precision Medicine = Massive 2020 Profits - Precision medicine just took a massive leap forward. This mega medical trend in personalized health care offers investors huge profit potential.
dinosaurs Dinosaur Stocks: No. 1 Biggest Mistake You Can Make in 2020 - It’s the most important factor in whether a stock is a superstar or a black hole for your money: innovation.
AI opportunity is coming in 2020 2 Great Ways to Play AI’s 343% Surge in 2020 - Here’s the best way to buy into the global AI market before it soars $12.4 billion by 2023.
Researchers have created microscopic robots that can deliver painkillers and cancer drugs, and even eat up artery-clogging cholesterol inside the body. Here’s the best way to play the rise of medical minibots for double-digit profits. 2 Ways to Invest in The Medical Robot Market Before it Skyrockets - Researchers have created microscopic robots that can deliver painkillers and cancer drugs, and even eat up artery-clogging cholesterol inside the body. Here’s the best way to play the rise of medical minibots for double-digit profits.
doctors of the future - precision medicine Best Buy for Precision Medicine’s 2020 Momentum - Meet the new face of personalized precision medicine — a revolution in health care that offers a genetics-based reboot of our “one size fits all” system.
The market for DNA testing will hit 60 million by 2021 with a new $100 test in the pipeline — a milestone likely to deliver huge gains to investors. 2 Genome Sequencing Stocks to Buy Today - The market for full-genome DNA testing will hit 60 million by 2021 with a new $100 test in the pipeline — a milestone likely to deliver huge gains to investors who get in on this mega medical trend now.
Beyond Turkey? Take Home Triple-Digit Gains This Holiday - Today, I’m going to tell you two ways to leverage the meatless market with investments that could have you giving thanks for years to come — regardless of whether a turkey graces your holiday table today.
3D printing and Payton Manning Peyton Manning Playbook: Catch 3D Printing Market’s 300% Growth - A spinal-implant company is tapping the 3D printing market, which is set to soar more than 300% — to $44.4 billion — by 2025. Here’s your ticket to riding this phenomenal mega tech trend for massive stock gains.
Next-Level AI “BioBots” = Unlimited Profit Potential - Medical robots are leading a new biotech revolution. Here’s the best way to buy into the global market for robotics, which is projected to skyrocket to $499 billion by 2025.

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

I am up $20,070 in closed positions from Feb. 18 through March 7.

- Bob Rowe

I started your system in December … I am ahead $29,000 … I put total faith in you and your system and it has worked for me very nicely. Thanks again I sure like your humble approach about this whole thing

- Dale Leiffer

I have made a little over $4,000 while being cautious.

- Chuck Goss